Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
Daiichi Sankyo
Shanu Modi; William Jacot; Toshinari Yamashita; Joohyuk Sohn; Maria Vidal; Eriko Tokunaga; Junji Tsurutani; Naoto T Ueno; Aleix Prat; Yee Soo Chae; Keun Seok Lee; Naoki Niikura; Yeon Hee Park; Binghe Xu; Xiaojia Wang; Miguel Gil-Gil; Wei Li; Jean-Yves Pierga; Seock-Ah Im; Halle C F Moore; Hope S Rugo; Rinat Yerushalmi; Flora Zagouri; Andrea Gombos; Sung-Bae Kim; Qiang Liu; Ting Luo; Cristina Saura; Peter Schmid; Tao Sun; Dhiraj Gambhire; Lotus Yung; Yibin Wang; Jasmeet Singh; Patrik Vitazka; Gerold Meinhardt; Nadia Harbeck; David A Cameron; DESTINY-Breast04 Trial Investigators